Gyre Therapeutics, Inc.GYRENASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank86
3Y CAGR-9.1%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
-9.1%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM0.02-55.0%
20240.05+103.5%
2023-1.41-4800.0%
20220.03+101.0%
2021-2.87+2.0%
2020-2.93+33.6%
2019-4.41-64.6%
2018-2.68+57.5%
2017-6.30+71.0%
2016-21.76-